Share Email Print
cover

Proceedings Paper

Optical fibre luminescence sensor for real-time LDR brachytherapy dosimetry
Author(s): P. Woulfe; S. O'Keeffe; F. J. Sullivan
Format Member Price Non-Member Price
PDF $17.00 $21.00

Paper Abstract

An optical fibre sensor for monitoring low dose radiation is presented. The sensor is based on a scintillation material embedded within the optical fibre core, which emits visible light when exposed to low level ionising radiation. The incident level of ionising radiation can be determined by analysing the optical emission. An optical fibre sensor is developed, based on radioluminescence whereby radiation sensitive scintillation material, terbium doped gadolinium oxysulphide (Gd2O2S:Tb), is embedded in a cavity of 700μm of a 1mm plastic optical fibre. The sensor is designed for in-vivo monitoring of the radiation dose during radio-active seed implantation for low dose rate (LDR) brachytherapy, in prostate cancer treatment, providing radiation oncologists with real-time information of the radiation dose to the target area and/or nearby organs at risk (OARs). The radiation from the brachytherapy seeds causes emission of visible light from the scintillation material through the process of radioluminescence, which penetrates the fibre, propagating along the optical fibre for remote detection using a multi-pixel photon counter. The sensor demonstrates a high sensitivity to 0.397mCi of Iodine125, the radioactive source most commonly used in brachytherapy for treating prostate cancer.

Paper Details

Date Published: 14 February 2018
PDF: 8 pages
Proc. SPIE 10488, Optical Fibers and Sensors for Medical Diagnostics and Treatment Applications XVIII, 1048813 (14 February 2018); doi: 10.1117/12.2287882
Show Author Affiliations
P. Woulfe, Univ. of Limerick (Ireland)
Galway Clinic (Ireland)
S. O'Keeffe, Univ. of Limerick (Ireland)
F. J. Sullivan, National Univ. of Ireland, Galway (Ireland)
Galway Clinic (Ireland)


Published in SPIE Proceedings Vol. 10488:
Optical Fibers and Sensors for Medical Diagnostics and Treatment Applications XVIII
Israel Gannot, Editor(s)

© SPIE. Terms of Use
Back to Top